thalidomide has been researched along with Osteomyelitis in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Osteomyelitis: INFLAMMATION of the bone as a result of infection. It may be caused by a variety of infectious agents, especially pyogenic (PUS - producing) BACTERIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thalidomide has a favorable safety profile compared with other alternatives and could be considered a feasible therapeutic option for this type of condition in selected patients." | 5.43 | Chronic Recurrent Multifocal Osteomyelitis and Thalidomide in Chronic Granulomatous Disease. ( Barber, I; Fernández-Polo, A; Fontecha, CG; Martín-Nalda, A; Martinez-Gallo, M; Roca, I; Soler-Palacin, P, 2016) |
| "Thalidomide has a favorable safety profile compared with other alternatives and could be considered a feasible therapeutic option for this type of condition in selected patients." | 1.43 | Chronic Recurrent Multifocal Osteomyelitis and Thalidomide in Chronic Granulomatous Disease. ( Barber, I; Fernández-Polo, A; Fontecha, CG; Martín-Nalda, A; Martinez-Gallo, M; Roca, I; Soler-Palacin, P, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azar, MM | 1 |
| Malinis, MF | 1 |
| Martín-Nalda, A | 1 |
| Roca, I | 1 |
| Fontecha, CG | 1 |
| Fernández-Polo, A | 1 |
| Barber, I | 1 |
| Martinez-Gallo, M | 1 |
| Soler-Palacin, P | 1 |
2 other studies available for thalidomide and Osteomyelitis
| Article | Year |
|---|---|
Disseminated Histoplasmosis with Skin Lesions and Osteomyelitis in a Patient from the Philippines.
Topics: Administration, Intravenous; Administration, Oral; Aged; Amphotericin B; Cefepime; Cephalosporins; D | 2016 |
Chronic Recurrent Multifocal Osteomyelitis and Thalidomide in Chronic Granulomatous Disease.
Topics: Child; Granulomatous Disease, Chronic; Humans; Immunosuppressive Agents; Male; Osteomyelitis; Radion | 2016 |